1
Nov 18 (Reuters) – Genomed SA: * SHAREHOLDERS AGREE TO SELL 47.14% STAKE IN COMPANY TO DIAGNOSTYKA FOR 33 ZLOTYS PER SHARE Source text: Further company coverage: (Reporting by Gdansk Newsroom)
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)